/
/
/

Acutaas Chemicals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020
₹437 Cr₹330 Cr₹433 Cr₹393 Cr₹306 Cr₹207 Cr₹308 Cr₹275 Cr₹247 Cr₹177 Cr₹225 Cr₹166 Cr₹172 Cr₹142 Cr₹186 Cr₹152 Cr₹147 Cr₹131 Cr₹144 Cr₹141 Cr₹122 Cr₹113 Cr₹93 Cr₹92 Cr₹91 Cr
₹5 Cr₹2 Cr₹11 Cr₹5 Cr₹10 Cr₹16 Cr₹6 Cr₹2 Cr₹8 Cr₹1 Cr₹1 Cr₹3 Cr₹2 Cr₹1 Cr-₹17 L₹3 Cr₹85 L₹62 L₹18 L₹1 Cr₹16 L₹1 Cr₹20,000₹17 L₹1 Cr
₹442 Cr₹331 Cr₹444 Cr₹398 Cr₹316 Cr₹223 Cr₹314 Cr₹277 Cr₹255 Cr₹178 Cr₹226 Cr₹170 Cr₹174 Cr₹143 Cr₹186 Cr₹155 Cr₹148 Cr₹132 Cr₹144 Cr₹143 Cr₹122 Cr₹114 Cr₹93 Cr₹92 Cr₹92 Cr
₹274 Cr₹226 Cr₹259 Cr₹252 Cr₹219 Cr₹164 Cr₹231 Cr₹213 Cr₹205 Cr₹153 Cr₹187 Cr₹144 Cr₹151 Cr₹121 Cr₹149 Cr₹125 Cr₹122 Cr₹111 Cr₹121 Cr₹114 Cr₹97 Cr₹93 Cr₹71 Cr₹71 Cr₹71 Cr
₹181 Cr₹115 Cr₹195 Cr₹155 Cr₹105 Cr₹67 Cr₹91 Cr₹70 Cr₹57 Cr₹31 Cr₹45 Cr₹30 Cr₹26 Cr₹26 Cr₹41 Cr₹34 Cr₹29 Cr₹24 Cr₹26 Cr₹31 Cr₹28 Cr₹23 Cr₹23 Cr₹22 Cr₹23 Cr
₹1 Cr₹1 Cr₹1 Cr₹86 L₹58 L₹64 L₹60 L₹69 L₹50 L₹4 Cr₹2 Cr₹3 Cr₹82 L₹51 L₹59 L₹1 Cr₹45 L₹18 L₹59 L₹34 L₹3 Cr₹3 Cr₹1 Cr₹2 Cr₹1 Cr
₹167 Cr₹104 Cr₹184 Cr₹145 Cr₹96 Cr₹58 Cr₹83 Cr₹63 Cr₹50 Cr₹20 Cr₹37 Cr₹24 Cr-₹10 Cr₹22 Cr₹37 Cr₹30 Cr₹26 Cr₹20 Cr₹22 Cr₹29 Cr₹23 Cr₹18 Cr₹21 Cr₹19 Cr₹20 Cr
₹123 Cr₹75 Cr₹134 Cr₹106 Cr₹72 Cr₹44 Cr₹63 Cr₹45 Cr₹38 Cr₹15 Cr₹26 Cr₹18 Cr-₹17 Cr₹17 Cr₹27 Cr₹22 Cr₹19 Cr₹15 Cr₹21 Cr₹19 Cr₹17 Cr₹14 Cr₹15 Cr₹14 Cr₹15 Cr

Share Price Live Stats

Open (₹)3,840.00
Volume (₹)4.31 L
High (₹)3,860.00
Upper Circuit4,532.70
Low (₹)3,742.50
Lower Circuit3,021.90
Prev Close3,777.30
52W High (₹)4,045.30
Price3,770.80
52W Low (₹)1,570.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)30928.00 Cr
Div. Yield (%)0.07
PE Ratio70.43
Debt to Equity0.02
Price to Book12.69
Book Value201.59
EPS (TTM)53.64
Face Value5.00
ROE (%)24.08

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
ACUTAASNSE
LTP
1W Low
1W High
Market cap (₹)
1829+51.3 (2.89%)
1722
1839.70
4,26,122Cr
10140.5+360.5 (3.69%)
9863
10159
2,66,424Cr
4710+96.6 (2.09%)
4553
4753.40
1,79,914Cr
2346-59.5 (-2.47%)
2252.40
2441.90
1,24,601Cr
1193-52.5 (-4.22%)
1172
1266.60
1,18,703Cr
1366+14 (1.04%)
1336.70
1384
1,14,599Cr
1404.1+25.2 (1.83%)
1364.60
1408
1,13,112Cr
2518+25.2 (1.01%)
2457.90
2561.20
1,04,631Cr
1785+103.6 (6.16%)
1656.20
1796.80
97,878Cr
1988-23 (-1.14%)
1944.10
2062.10
92,145Cr
3770.8-232.8 (-5.81%)
3742.50
4045.30
30,928Cr
Empty box

No content available